NYSE:BAX - Baxter International Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$72.20 +0.16 (+0.22 %)
(As of 08/21/2018 06:33 AM ET)
Previous Close$72.04
Today's Range$71.96 - $72.43
52-Week Range$60.53 - $76.51
Volume1.70 million shs
Average Volume3.14 million shs
Market Capitalization$38.49 billion
P/E Ratio26.20
Dividend Yield1.05%
Beta0.77
Baxter International logoBaxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:BAX
CUSIP07181310
Phone224-948-2000

Debt

Debt-to-Equity Ratio0.39
Current Ratio2.62
Quick Ratio2.00

Price-To-Earnings

Trailing P/E Ratio26.20
Forward P/E Ratio24.23
P/E Growth1.95

Sales & Book Value

Annual Sales$10.56 billion
Price / Sales3.65
Cash Flow$3.9303 per share
Price / Cash18.37
Book Value$16.73 per share
Price / Book4.32

Profitability

EPS (Most Recent Fiscal Year)$2.48
Net Income$717 million
Net Margins8.29%
Return on Equity16.63%
Return on Assets8.92%

Miscellaneous

Employees47,000
Outstanding Shares534,270,000
Market Cap$38.49 billion

Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, July 17th. Shareholders of record on Friday, August 31st will be given a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Thursday, August 30th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International announced that its Board of Directors has approved a share repurchase plan on Wednesday, February 21st 2018, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Thursday, July, 26th. The medical instruments supplier reported $0.77 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.71 by $0.06. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.83 billion. Baxter International had a return on equity of 16.63% and a net margin of 8.29%. Baxter International's quarterly revenue was up 9.1% compared to the same quarter last year. During the same period last year, the business earned $0.63 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Baxter International.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY18 earnings guidance on Thursday, July, 26th. The company provided earnings per share guidance of $2.94-3.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.89. Baxter International also updated its Q3 guidance to $0.72-0.74 EPS.

What price target have analysts set for BAX?

13 brokerages have issued 12-month price targets for Baxter International's stock. Their forecasts range from $62.00 to $85.00. On average, they expect Baxter International's stock price to reach $75.6154 in the next year. This suggests a possible upside of 4.7% from the stock's current price. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Who are some of Baxter International's key competitors?

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 45)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 55)
  • Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47)

Has Baxter International been receiving favorable news coverage?

Media stories about BAX stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Baxter International earned a news and rumor sentiment score of 0.05 on Accern's scale. They also gave news headlines about the medical instruments supplier an impact score of 47.43 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for Baxter International.

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.82%), FMR LLC (5.36%), Veritas Asset Management LLP (1.65%), Wells Fargo & Company MN (1.07%), Bank of New York Mellon Corp (0.82%) and Janus Henderson Group PLC (0.75%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Partner Fund Management L.P., Canada Pension Plan Investment Board, Renaissance Technologies LLC, Veritas Asset Management LLP, Great West Life Assurance Co. Can, Starboard Value LP and Schwab Charles Investment Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Voya Investment Management LLC, Morgan Stanley, Standard Life Aberdeen plc, SPF Beheer BV, Marshall Wace LLP, Obermeyer Wood Investment Counsel Lllp and Putnam Investments LLC. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $72.20.

How big of a company is Baxter International?

Baxter International has a market capitalization of $38.49 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  540 (Vote Outperform)
Underperform Votes:  470 (Vote Underperform)
Total Votes:  1,010
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel